Furthermore, a number of studies have reported the down-regulated expression of ACE2 in various tumors such as breast tumors [25], non-small cell lung cancer [26], pancreatic ductal adenocarcinoma [27], and gallbladder cancer[28]. This evidence concerns the gene ACE2 and breast neoplasm.